1 Answer
Ranbaxy, an India-based pharmaceutical company, agreed to delay release of its generic version of Lipitor until Nov. 30.
According to its website, Ranbaxy will have the exclusive right to sell its drug in the U.S. for six months.
Experts say when generic versions of these drugs make it to market, pharmaceutical companies could face billions in potential losses, while consumers could save tens of billions of dollars a year.
12 years ago. Rating: 0 | |
Top contributors in Uncategorized category
Unanswered Questions
AE888 VENUS - ĐĂNG KÝ ĐĂNG NHẬP AE888 CASINO ONLINE
Answers: 0
Views: 13
Rating: 0
Cwin
Answers: 0
Views: 16
Rating: 0
Cwin
Answers: 0
Views: 16
Rating: 0
How to Market NFT?
Answers: 0
Views: 19
Rating: 0
Tribrid Packaging
Answers: 0
Views: 18
Rating: 0
HB88
Answers: 0
Views: 19
Rating: 0
RikVip Club - Vén màn bí mật "Thế giới ngầm" cá cược trực tuyến
Answers: 0
Views: 18
Rating: 0
nhacai888bin
> More questions...
Answers: 0
Views: 16
Rating: 0